Form 8-K - Current report:
SEC Accession No. 0001062822-24-000054
Filing Date
2024-10-16
Accepted
2024-10-16 16:37:25
Documents
13
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20241016.htm   iXBRL 8-K 24334
  Complete submission text file 0001062822-24-000054.txt   148617

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20241016.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20241016_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20241016_pre.xml EX-101.PRE 12504
16 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20241016_htm.xml XML 3014
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 241375045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)